Scoring nail psoriasis

Klaassen, Karlijn M.G.; Kerkhof, Peter C M van de; Bastiaens, Maarten T.; Plusjé, Leon G. J. M.; Baran, Robert; Pasch, Marcel C.

doi:10.1016/j.jaad.2014.02.010

Cited by 60 publications

(57 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A limited number of studies have used target‐NAPSI score, as initially designed by Rich and Scher in 2003, to determine nail psoriasis severity, with many opting for alternatives like the total NAPSI and/or a modified NAPSI or target‐NAPSI score instead. The mean target‐NAPSI score calculated in our study was found higher than that of a study that took place at the same Psoriasis Outpatient Clinic and similar to that of 2 Dutch studies . It was, however, lower than that of people requiring treatment with biologic agents .…”

Section: Discussionsupporting

confidence: 60%

“…The participants in our study had a mean DLQI score of 10.17 (7.46, 12.89), which corresponds to moderate to severe psoriasis . The mean DLQI score of our study subjects was found to be higher than that of participants in some studies (no statistical comparison) including a large German study that examined 4863 psoriasis patients . This finding can perhaps be explained through the observation that psoriasis patients with nail lesions tend to have higher DLQI scores compared to those without .…”

Section: Discussionmentioning

confidence: 44%

See 1 more Smart Citation

Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study

Tsentemeidou

Vyzantiadis

Kyriakou

et al. 2017

Mycoses

View full text Add to dashboard Cite

Nail psoriasis and onychomycosis can often be hard to differentiate clinically and may coexist, complicating each other's course. The aim of this study was to determine the prevalence of onychomycosis among patients with nail psoriasis not being treated with immunosuppressive agents, which constitute an independent risk factor for fungal infections. A cross-sectional study was performed. All adult patients with nail psoriasis who were not receiving antifungal and/or immunosuppressive treatment were recruited at the 2nd University Dermatology Department of Aristotle University of Thessaloniki from 10/2016 till 02/2017. If onychomycosis was clinically suspected, nail samples were collected and direct microscopy with 15% KOH solution and culture were performed. Target-NAPSI and DLQI score were also calculated. Of the 23 patients recruited, 20 were men and 3 were women, with a mean age of 53.43 years (48.25, 58.62), a mean target-NAPSI score of 10.72 (9.62, 11.77) and a mean DLQI score of 10.17 (7.46, 12.89). A total of 34.78% of patients tested positive for onychomycosis. Yeast were isolated in 37.50% of cases, non-dermatophyte filamentous fungi in 37.50% and T. rubrum in 12.50%. The prevalence of onychomycosis among nail psoriasis patients is higher than that among the general population of Greece (15%-20%). Yeast and moulds predominate in infection cases of nail psoriasis patients.

show abstract

Section: Discussionsupporting

confidence: 60%

Section: Discussionmentioning

confidence: 44%

Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study

Tsentemeidou

Vyzantiadis

Kyriakou

et al. 2017

Mycoses

View full text Add to dashboard Cite

show abstract

“…Over the last two decades multiple outcome instruments have been developed . Each of these tools scores the absence or presence of nail features, but they differ in the selection and methods used to assess included nail features.…”

mentioning

confidence: 99%

Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Tüm psoriasis tırnak indekslerinin eksiklikleri gözden geçirilerek geliştirilmiş olan bu ölçekte, tüm el tırnakları onikoliz/yağ damlası diskolorasyonu (yok=0, %0-25=1, %25-50=2, >%50=3), pitting (yok=0, hafif=1, orta=2, şiddetli=3), ufalanma (yok=0, hafif=1, orta=2, şiddetli=3), Beau çizgileri (yok=0, 1 Beau çizgisi=1, 2 Beau çizgisi=2, ≥3 Beau çizgisi=3) bulguları açısından skorlanarak toplam skor elde edilmektedir 114 .…”

Section: Nijmegen-tırnak Psoriasis Aktivite İndeks Aracıunclassified

Disease severity scoring systems in dermatology

Bilaç¹,

Şahin²,

Öztürkcan³

2016

TURKDERM

View full text Add to dashboard Cite

Scoring systems have been developed to interpret the disease severity objectively by evaluating the parameters of the disease. Body surface area, visual analogue scale, and physician global assessment are the most frequently used scoring systems for evaluating the clinical severity of the dermatological diseases. Apart from these scoring systems, many specific scoring systems for many dermatological diseases, including acne (acne vulgaris, acne scars), alopecia (androgenetic alopecia, tractional alopecia), bullous diseases (autoimmune bullous diseases, toxic epidermal necrolysis), dermatitis (atopic dermatitis, contact dermatitis, dyshidrotic eczema), hidradenitis suppurativa, hirsutismus, connective tissue diseases (dermatomyositis, skin involvement of systemic lupus erythematosus (LE), discoid LE, scleroderma), lichen planoplaris, mastocytosis, melanocytic lesions, melasma, onychomycosis, oral lichen planus, pityriasis rosea, psoriasis (psoriasis vulgaris, psoriatic arthritis, nail psoriasis), sarcoidosis, urticaria, and vitiligo, have also been developed. Disease severity scoring methods are ever more extensively used in the field of dermatology for clinical practice to form an opinion about the prognosis by determining the disease severity; to decide on the most suitable treatment modality for the patient; to evaluate the efficacy of the applied medication; and to compare the efficiency of different treatment methods in clinical studies. Keywords: Disease severity, scoring system, dermatology Skorlama sistemleri, hastalığa ait parametrelerin değerlendirilerek hastanın klinik şiddetini objektif olarak saptama amacıyla geliştirilmiş olan ölçeklerdir. Vücut yüzey alanı, görsel analog skala ve doktor global değerlendirme skoru dermatolojik hastalıkların klinik şiddetinin değerlendirilmesi amacıyla en sık kullanılan genel skorlama sistemleridir. Bu skorlama sistemleri dışında akne (akne vulgaris, akne skarları), alopesi (androgenetik alopesi, traksiyonel alopesi), Behçet hastalığı, büllöz hastalıklar (otoimmün büllöz hastalıklar, toksik epidermal nekroliz, epidermolizis bülloza), dermatit (atopik dermatit, kontakt dermatit, dishidrotik egzama), hidradenitis suppurativa, hirsutismus, konnektif doku hastalıkları (dermatomyozit, sistemik lupus eritematozusun (LE) deri tutulumu, diskoid LE, skleroderma), liken planopilaris, mastositoz, melanositik lezyonlar-melanom, melazma, mikozis fungoides/Sezary sendromu, onikomikoz, oral liken planus, pitiriyazis rozea, psoriasis (psoriasis vulgaris, psoriatik artrit, tırnak psoriasisi), sarkoidoz, ürtiker ve anjiyoödem ve vitiligo gibi çok sayıda dermatolojik hastalık için spesifik skorlama sistemleri de geliştirilmiştir. Hastalık şiddet skorlama yöntemleri, dermatoloji alanında klinik pratikte hastalığın şiddetinin belirlenerek prognoz hakkında fikir sahibi olunabilmesi, hasta için uygun tedavinin belirlenmesi, uygulanan tedavinin etkinliğinin değerlendirilmesi, klinik araştırmalarda ise farklı tedavi yöntemlerinin etkinliklerinin karşılaştırılabilmesi gibi amaçlarla giderek d...

show abstract

Scoring nail psoriasis

Cited by 60 publications

References 27 publications

Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study

Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study

Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review

Disease severity scoring systems in dermatology

Contact Info

Product

Resources

About